This invention relates to a method for reducing a condition associated with fetal alcohol syndrome in a subject who is exposed to alcohol in utero with an ADNF polypeptide. In particular, the present invention relates to a method of reducing a condition associated with fetal alcohol syndrome in a subject who is exposed to alcohol in utero with a combination of ADNF I and ADNF III polypeptides. The present invention further relates to a method for reducing neuronal cell death by contacting neuronal cells with a combination of ADNF I and ADNF III polypeptides. Still further, the present invention relates to a pharmaceutical composition comprising a combination of ADNF I and ADNF III polypeptides.

 
Web www.patentalert.com

< Cell separation compositions and methods

< Use of non-peptidyl compounds for the treatment of insulin related ailments

> Treatment of hypertension using growth hormone in mammals subjected to fetal programming

> Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
~ 00201